![]() |
![]() |
Legal status
Patent revoked (after opposition at EPO)
(51) | INT.CL. | A61K 31/4439 | (2006.01) |
A61K 47/12 | (2006.01) | ||
A61K 9/20 | (2006.01) | ||
A61K 9/28 | (2006.01) | ||
A61K 31/519 | (2006.01) |
(11) | Number of the document | 3302565 |
(13) | Kind of document | T |
(96) | European patent application number | 16726192.4 |
Date of filing the European patent application | 2016-05-24 | |
(97) | Date of publication of the European application | 2018-04-11 |
(45) | Date of publication and mention of the grant of the patent | 2019-11-06 |
(46) | Date of publication of the claims translation | 2019-12-27 |
(86) | Number | PCT/IB2016/053040 |
Date | 2016-05-24 |
(87) | Number | WO 2016/193860 |
Date | 2016-12-08 |
(30) | Number | Date | Country code |
201562171177 P | 2015-06-04 | US | |
201662332973 P | 2016-05-06 | US |
(72) |
IBRAHIM, Fady Makram Louiz, US
MULLARNEY, Matthew Patrick, US
SHANKER, Ravi Mysore, US
SPONG, Barbara Rodriguez, US
WANG, Jian, US
|
(73) |
Pfizer Inc. ,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Kietos palbociklibo dozavimo formos |
SOLID DOSAGE FORMS OF PALBOCICLIB |
Payment date | Validity (years) | Amount | |
2024-04-16 | 9 | 208.00 EUR |
Patent revoked (after opposition at EPO) | ||
Invalidation date | 2024-10-14 |